AFNAS
ECYT

American Financial Network Advisory Services’s Endocyte, Inc. Common Stock ECYT Stock Holding History

American Financial Network Advisory Services’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-79
Closed – – 810
2017
Q3 		$0 Buy
+79
New +$110 ﹤0.01% 778

Other funds holding ECYT

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Financial Network Advisory Services's ECYT Position: Q4 2017 in Review

American Financial Network Advisory Services sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2017, closing a stake of 79 shares.

American Financial Network Advisory Services first reported a position in ECYT in Q3 2017 and held it in 1 quarter. The position peaked at $0 in Q3 2017. 71 funds tracked by Wall St. Rank hold ECYT as of Q4 2017.

  • American Financial Network Advisory Services reported no remaining Endocyte, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • American Financial Network Advisory Services sold 79 Endocyte, Inc. Common Stock shares in Q4 2017.
  • American Financial Network Advisory Services first reported a position in Endocyte, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • American Financial Network Advisory Services's Endocyte, Inc. Common Stock position peaked at $0 in Q3 2017.
  • 71 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2017.

Based on American Financial Network Advisory Services's 13F filing for Q4 2017, filed 2 Jan 2018.